SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
XBI Stock Price Chart Interactive Chart >
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $131.91 | 52-week high | $174.79 |
| Prev. close | $130.37 | 52-week low | $109.82 |
| Day low | $129.61 | Volume | 4,715,400 |
| Day high | $132.75 | Avg. volume | 6,058,173 |
| 50-day MA | $128.35 | Dividend yield | 0.23% |
| 200-day MA | $137.35 |
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 7.51B |
| Net Asset Value (NAV) | $130.20 |
| Options? | Yes |
| Total Holdings | 191 |
XBI Top Holdings
| Symbol | Company | % of Total |
| XLRN | ACCELERON PHARMA INC | 0.87% |
| CCXI | ChemoCentryx Inc | 0.84% |
| CYTK | Cytokinetics Incorporated | 0.82% |
| MCRB | Seres Therapeutics Inc | 0.81% |
| SRPT | Sarepta Therapeutics Inc | 0.81% |
| IOVA | Iovance Biotherapeutics Inc | 0.81% |
| ALLO | Allogene Therapeutics | 0.8% |
| DVAX | DYNAVAX TECHNO | 0.8% |
| TGTX | TG Therapeutics Inc | 0.8% |
| BPMC | Blueprint Medicines Corp | 0.8% |
XBI Price Returns
| 1-mo | -0.09% |
| 3-mo | -2.58% |
| 6-mo | -3.74% |
| 1-year | 19.08% |
| 3-year | 37.95% |
| 5-year | 102.86% |
| YTD | -6.27% |
| 2020 | 48.33% |
| 2019 | 32.56% |
| 2018 | -15.28% |
| 2017 | 43.77% |
| 2016 | -15.45% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||